Induced hypernatremia in patients with moderate-to-severe ARDS: a randomized controlled study

被引：0
|
作者：
Shailesh Bihari
Shivesh Prakash
Dani L. Dixon
Elena Cavallaro
Andrew D. Bersten
机构：
[1] Department of ICCU,College of Medicine and Public Health
[2] Flinders Medical Centre,undefined
[3] Flinders University,undefined
来源：
Intensive Care Medicine Experimental | / 9卷
关键词：
ARDS; Hypernatremia; Hyperosmolarity; Lung injury score; Mechanical Ventilation; Randomized control study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study
    Amidfar, M.
    Khiabany, M.
    Kohi, A.
    Salardini, E.
    Arbabi, M.
    Azizi, M. Roohi
    Zarrindast, M. -R.
    Mohammadinejad, P.
    Zeinoddini, A.
    Akhondzadeh, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (01) : 44 - 50
  • [42] Extended-release tramadol/paracetamol in moderate-to-severe pain: a randomized, placebo-controlled study in patients with acute low back pain
    Lasko, Ben
    Levitt, Randy J.
    Rainsford, K. D.
    Bouchard, Sylvie
    Rozova, Anna
    Robertson, Sybil
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (05) : 847 - 857
  • [43] A Randomized Controlled Trial of Community-Delivered Heated Hatha Yoga for Moderate-to-Severe Depression
    Nyer, Maren B.
    Hopkins, Lindsey B.
    Nagaswami, Megha
    Norton, Richard
    Streeter, Chris C.
    Hoeppner, Bettina B.
    Sorensen, Chloe E. C.
    Uebelacker, Lisa
    Koontz, Jill
    Foster, Simmie
    Dording, Christina
    Giollabhui, Naoise Mac
    Yeung, Albert
    Fisher, Lauren B.
    Cusin, Cristina
    Jain, Felipe A.
    Pedrelli, Paola
    Ding, Grace A.
    Mason, Ashley E.
    Cassano, Paolo
    Mehta, Darshan H.
    Sauder, Christina
    Raison, Charles L.
    Miller, Karen K.
    Fava, Maurizio
    Mischoulon, David
    JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (06)
  • [44] A NETWORK META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS OF USTEKINUMAB AND ADALIMUMAB FOR MODERATE-TO-SEVERE PSORIASIS
    Odom, D.
    Brogan, A.
    Talbird, S. E.
    Schenkel, B.
    VALUE IN HEALTH, 2013, 16 (03) : A112 - A112
  • [45] Placebo Response in Moderate-to-Severe Psoriasis: Prevalence Meta-Analysis of Randomized Controlled Trials
    Afach, Sivem
    Le, Laurence
    Sbidian, Emilie
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (06) : 1101 - 1104
  • [46] Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)
    Gyldenlove, Mette
    Meteran, Howraman
    Sorensen, Jennifer A.
    Fage, Simon
    Yao, Yiqiu
    Lindhardsen, Jesper
    V. Nissen, Christoffer
    Todberg, Tanja
    Thomsen, Simon F.
    Skov, Lone
    Zachariae, Claus
    Iversen, Lars
    Nielsen, Mia -Louise
    Egeberg, Alexander
    LANCET REGIONAL HEALTH-EUROPE, 2023, 30
  • [47] Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Cyrille, Marcoli
    Hansen, Mark Berner
    Feagan, Brian G.
    Loftus, Edward V., Jr.
    Rogler, Gerhard
    Vermeire, Severine
    Cruz, Martha L.
    Yang, Jun
    Boedigheimer, Michael J.
    Abuqayyas, Lubna
    Evangelista, Christine M.
    Sullivan, Barbara A.
    Reinisch, Walter
    GASTROENTEROLOGY, 2019, 156 (04) : 946 - +
  • [48] Moderate-to-severe pain after knee arthroscopy is relieved by intraarticular saline: A randomized controlled trial
    Rosseland, LA
    Helgesen, KG
    Breivik, H
    Stubhaug, A
    ANESTHESIA AND ANALGESIA, 2004, 98 (06): : 1546 - 1551
  • [49] Deucravacitinib for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Toth, Otavio A. S.
    Meldola, Patrick F.
    Machado, Pablo G.
    Chiarelli, Gabriel F. C.
    Schnorrenberger, Erick
    Kracik, Jose L. S.
    de Carvalho, Caio C.
    Guzatti, Joao V. L.
    Mease, Philip J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (02) : 67 - 73
  • [50] Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials
    Blauvelt, A.
    Reich, K.
    Papp, K. A.
    Kimball, A. B.
    Gooderham, M.
    Tyring, S. K.
    Sinclair, R.
    Thaci, D.
    Li, Q.
    Cichanowitz, N.
    Green, S.
    La Rosa, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (03) : 615 - 622
12345